Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics

ClinicalTrials.gov ID: NCT00773279

Public ClinicalTrials.gov record NCT00773279. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 9:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-centre, Randomised, Open-label, Cross-over Study to Explore Effectiveness, Safety, and Preference of a New Disposable Pen PDS290 Versus FlexPen® in Subjects With Type 1 or Type 2 Diabetes

Study identification

NCT ID
NCT00773279
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
242 participants

Conditions and interventions

Interventions

  • FlexPen® Device
  • FlexTouch® Device

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2008
Primary completion
May 31, 2009
Completion
May 31, 2009
Last update posted
Mar 26, 2017

2008 – 2009

United States locations

U.S. sites
65
U.S. states
28
U.S. cities
62
Facility City State ZIP Site status
Novo Nordisk Investigational Site Burlingame California 94010
Novo Nordisk Investigational Site Concord California 94520
Novo Nordisk Investigational Site Encino California 91436
Novo Nordisk Investigational Site Escondido California 92025
Novo Nordisk Investigational Site Fresno California 93720
Novo Nordisk Investigational Site Mission Viejo California 92691
Novo Nordisk Investigational Site Orange California 92869
Novo Nordisk Investigational Site Poway California 92064
Novo Nordisk Investigational Site Salinas California 93901
Novo Nordisk Investigational Site Santa Monica California 90404
Novo Nordisk Investigational Site Tustin California 92780
Novo Nordisk Investigational Site Walnut Creek California 94598
Novo Nordisk Investigational Site Aurora Colorado 80045
Novo Nordisk Investigational Site Colorado Springs Colorado 80909
Novo Nordisk Investigational Site Golden Colorado 80401
Novo Nordisk Investigational Site Boca Raton Florida 33433
Novo Nordisk Investigational Site Hollywood Florida 33021
Novo Nordisk Investigational Site Maitland Florida 32751
Novo Nordisk Investigational Site Miami Florida 33143
Novo Nordisk Investigational Site Miami Florida 33156
Novo Nordisk Investigational Site Ocala Florida 34471
Novo Nordisk Investigational Site Tallahassee Florida 32308
Novo Nordisk Investigational Site Athens Georgia 30606
Novo Nordisk Investigational Site Atlanta Georgia 30318
Novo Nordisk Investigational Site Roswell Georgia 30076
Novo Nordisk Investigational Site Savannah Georgia 31406
Novo Nordisk Investigational Site Honolulu Hawaii 96814
Novo Nordisk Investigational Site Chicago Illinois 60607
Novo Nordisk Investigational Site Chicago Illinois 60616
Novo Nordisk Investigational Site Lafayette Indiana 47904
Novo Nordisk Investigational Site Wichita Kansas 67226
Novo Nordisk Investigational Site Bowling Green Kentucky 42101-1759
Novo Nordisk Investigational Site Lexington Kentucky 40503
Novo Nordisk Investigational Site Metairie Louisiana 70002
Novo Nordisk Investigational Site Baltimore Maryland 21204
Novo Nordisk Investigational Site Hyattsville Maryland 20782
Novo Nordisk Investigational Site Rockville Maryland 20852
Novo Nordisk Investigational Site Jefferson City Missouri 65109
Novo Nordisk Investigational Site St Louis Missouri 63141
Novo Nordisk Investigational Site Butte Montana 59701
Novo Nordisk Investigational Site Omaha Nebraska 68114
Novo Nordisk Investigational Site Las Vegas Nevada 89030
Novo Nordisk Investigational Site Las Vegas Nevada 89101
Novo Nordisk Investigational Site Berlin New Jersey 08009
Novo Nordisk Investigational Site Lawrenceville New Jersey 08648
Novo Nordisk Investigational Site Asheville North Carolina 28803
Novo Nordisk Investigational Site Tabor City North Carolina 28463
Novo Nordisk Investigational Site Fargo North Dakota 58104
Novo Nordisk Investigational Site Dayton Ohio 45439
Novo Nordisk Investigational Site Gallipolis Ohio 45631-1560
Novo Nordisk Investigational Site Kettering Ohio 45429
Novo Nordisk Investigational Site Mentor Ohio 44060
Novo Nordisk Investigational Site Medford Oregon 97504-8491
Novo Nordisk Investigational Site Altoona Pennsylvania 16602
Novo Nordisk Investigational Site Carlisle Pennsylvania 17015
Novo Nordisk Investigational Site Little River South Carolina 29566
Novo Nordisk Investigational Site Chattanooga Tennessee 37411
Novo Nordisk Investigational Site Arlington Texas 76014
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Hurst Texas 76054
Novo Nordisk Investigational Site San Antonio Texas 78229
Novo Nordisk Investigational Site Ogden Utah 84403
Novo Nordisk Investigational Site Virginia Beach Virginia 23462
Novo Nordisk Investigational Site Renton Washington 98057
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00773279, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 26, 2017 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00773279 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →